FR2325387B1 - - Google Patents

Info

Publication number
FR2325387B1
FR2325387B1 FR7629064A FR7629064A FR2325387B1 FR 2325387 B1 FR2325387 B1 FR 2325387B1 FR 7629064 A FR7629064 A FR 7629064A FR 7629064 A FR7629064 A FR 7629064A FR 2325387 B1 FR2325387 B1 FR 2325387B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7629064A
Other versions
FR2325387A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2325387A1 publication Critical patent/FR2325387A1/fr
Application granted granted Critical
Publication of FR2325387B1 publication Critical patent/FR2325387B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR7629064A 1975-09-29 1976-09-28 Preparations antigeniques et medicament comprenant ces preparations Granted FR2325387A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB39857/75A GB1564500A (en) 1975-09-29 1975-09-29 Biological preparations

Publications (2)

Publication Number Publication Date
FR2325387A1 FR2325387A1 (fr) 1977-04-22
FR2325387B1 true FR2325387B1 (fr) 1980-06-27

Family

ID=10411873

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7629064A Granted FR2325387A1 (fr) 1975-09-29 1976-09-28 Preparations antigeniques et medicament comprenant ces preparations

Country Status (15)

Country Link
JP (1) JPS5244228A (fr)
AU (1) AU514848B2 (fr)
BE (1) BE846681A (fr)
BG (1) BG34181A3 (fr)
CA (1) CA1079634A (fr)
DD (1) DD127598A5 (fr)
DE (1) DE2643641A1 (fr)
ES (1) ES451923A1 (fr)
FR (1) FR2325387A1 (fr)
GB (1) GB1564500A (fr)
HU (1) HU176180B (fr)
NL (1) NL7610736A (fr)
PL (1) PL103082B1 (fr)
SE (1) SE7610708L (fr)
ZA (1) ZA765817B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148876A (en) 1975-09-29 1979-04-10 Burroughs Wellcome Co. Biological preparations
US4196191A (en) 1975-09-29 1980-04-01 Burroughs Wellcome Co. Biological preparations
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
GB2026340B (en) * 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
US4201767A (en) * 1978-11-08 1980-05-06 Merck & Co., Inc. Viral liposome particle
US4199565A (en) 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
HU184141B (en) * 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
DE3173713D1 (en) * 1980-09-05 1986-03-20 Frappier Armand Inst Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
FR2543018B1 (fr) * 1983-03-22 1985-07-26 Oreal Procede de preparation de vesicules lipidiques par vaporisation de solvants
IT1238343B (it) * 1989-10-16 1993-07-13 Cesalpino Andrea Fond Procedimento per la preparazione di vaccini capaci di generare non solo la risposta immune dei linfociti t helper,ma anche un'efficace risposta di linfociti t citotossici,e vaccini con queste caratteristiche
EP0640347A1 (fr) * 1992-03-03 1995-03-01 Daiichi Pharmaceutical Co., Ltd. Vaccin oral
US6096291A (en) * 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
CN105899220B (zh) * 2013-12-19 2020-01-10 扬森疫苗与预防公司 改进的病毒体配制品

Also Published As

Publication number Publication date
DD127598A5 (de) 1977-10-05
SE7610708L (sv) 1977-03-30
HU176180B (en) 1980-12-28
NL7610736A (nl) 1977-03-31
JPS5244228A (en) 1977-04-07
AU1816476A (en) 1978-04-06
PL103082B1 (pl) 1979-05-31
ES451923A1 (es) 1977-08-16
GB1564500A (en) 1980-04-10
CA1079634A (fr) 1980-06-17
DE2643641A1 (de) 1977-04-14
BG34181A3 (en) 1983-07-15
BE846681A (fr) 1977-03-28
FR2325387A1 (fr) 1977-04-22
AU514848B2 (en) 1981-03-05
ZA765817B (en) 1978-05-30

Similar Documents

Publication Publication Date Title
FR2322192B1 (fr)
FR2314281B1 (fr)
FR2325615B1 (fr)
JPS5541320Y2 (fr)
JPS50152845A (fr)
JPS5242637Y2 (fr)
JPS5616328B2 (fr)
JPS5227364U (fr)
JPS5418457Y2 (fr)
JPS5649125Y2 (fr)
JPS51152435U (fr)
JPS5278952U (fr)
JPS5225049U (fr)
JPS51146495U (fr)
JPS5275156U (fr)
JPS5265592U (fr)
CH606574A5 (fr)
CH608598A5 (fr)
CH609611A5 (fr)
CH599465A5 (fr)
CH609506A5 (fr)
CH598170A5 (fr)
CH609221A5 (fr)
CH600555A5 (fr)
BG22202A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse